Kelly Brady insider trades: Seres Therapeutics (MCRB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kelly reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | MCRB | ↓ Sell | 64 | $4.55 | $291 | Direct | Aug 18, 2026 (1d) |
| May 18, 2026 | MCRB | ↓ Sell | 59 | $7.53 | $444 | Direct | May 19, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MCRB insiders
Open-market trades in the last 12 months
About Kelly Brady's insider trades
Kelly Brady is See Remarks at Seres Therapeutics (MCRB). Since May 18, 2026, Kelly has reported no open-market purchases and 2 sales worth $735 on SEC Form 4. In the last 12 months: 2 sales ($735).
Their filings also include option exercises (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MCRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.